MedPath
NMPA Approval

Ruxolitinib Phosphate Tablets

国药准字H20249398

November 15, 2024

Drug Information

磷酸芦可替尼片

片剂

5mg(按C₁₇H₁₈N₆计)

化学药品

November 15, 2024

Company Information

Applicant Company

成都高新区西源大道8号

Manufacturing Company

成都高新区西源大道8号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

磷酸芦可替尼片 - NMPA 批准文号 | MedPath